CDK9-dependent transcriptional elongation in the innate interferon-stimulated gene response to respiratory syncytial virus infection in airway epithelial cells

Journal of Virology

Volumn 87, Issue 12, 2013, Pages 7075-7092

  Tian, Bing ^a   Zhao, Yingxin ^a,b   Kalita, Mridul ^a   Edeh, Chukwudi B ^a   Paessler, Slobodan ^a,b   Casola, Antonella ^a,b   Teng, Michael N ^c   Garofalo, Roberto P ^a,b   Brasier, Allan R ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; CYCLIN DEPENDENT KINASE 9; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; INTERFERON STIMULATED GENE FACTOR 3; NONSTRUCTURAL PROTEIN 1; NUCLEAR RNA; RNA POLYMERASE II; SMALL INTERFERING RNA; STAT1 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS PROTEIN N;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL SURVIVAL; CELL VIABILITY; CHROMATIN; CIG5 GENE; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOMODULATION; INNATE IMMUNITY; INTERFERON STIMULATED GENE 54; INTERFERON STIMULATED GENE 56; INTRACELLULAR SIGNALING; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; TRANSCRIPTION ELONGATION; VIRUS CELL INTERACTION; VIRUS REPLICATION;

CELL LINE; CHROMATIN IMMUNOPRECIPITATION; CYCLIN-DEPENDENT KINASE 9; EPITHELIAL CELLS; HUMANS; IMMUNITY, INNATE; INTERFERON REGULATORY FACTOR-3; INTERFERONS; LUNG; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; TRANSCRIPTION FACTORS;

RESPIRATORY SYNCYTIAL VIRUS; RICE STRIPE VIRUS; RNA VIRUSES;

EID: 84878573103     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03399-12     Document Type: Article

References (74)

1. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, O'Brien KL, Roca A, Wright PF, Bruce N, Chandran A, Theodoratou E, Sutanto A, Sedyaningsih ER, Ngama M, Munywoki PK, Kartasasmita C, Simoes EA, Rudan I, Weber MW, Campbell H. 2010. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375:1545- 1555.
2. Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, Auinger P, Griffin MR, Poehling KA, Erdman D, Grijalva CG, Zhu Y, Szilagyi P. 2009. The burden of respiratory syncytial virus infection in young children. N. Engl. J. Med. 360:588-598.
3. Mohapatra SS, Boyapalle S. 2008. Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma. Clin. Microbiol. Rev. 21:495-504.
4. Shay DK, Holman RC, Roosevelt GE, Clarke MJ, Anderson LJ. 2001. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. J. Infect. Dis. 183:16-22.
5. Zorc JJ, Hall CB. 2010. Bronchiolitis: recent evidence on diagnosis and management. Pediatrics 125:342-349.
6. Haeberle HA, Casola A, Gatalica Z, Petronella S, Dieterich HJ, Ernst PB, Brasier AR, Garofalo RP. 2004. IkappaB kinase is a critical regulator of chemokine expression and lung inflammation in respiratory syncytial virus infection. J. Virol. 78:2232-2241.
7. Hall CB, Douglas RG, Jr, Schnabel KC, Geiman JM. 1981. Infectivity of respiratory syncytial virus by various routes of inoculation. Infect. Immun. 33:779-783.
8. Aherne W, Bird T, Court SD, Gardner PS, McQuillin J. 1970. Pathological changes in virus infections of the lower respiratory tract in children. J. Clin. Pathol. 23:7-18.
9. Garofalo R, Sabry M, Jamaluddin M, Yu RK, Casola A, Ogra PL, Brasier AR. 1996. Transcriptional activation of the interleukin-8 gene by respiratory syncytial virus infection in alveolar epithelial cells: nuclear translocation of the RelA transcription factor as a mechanism producing airway mucosal inflammation. J. Virol. 70:8773-8781.
10. Brasier AR, Tian B, Jamaluddin M, Kalita MK, Garofalo RP, Lu M. 2011. RelA Ser276 phosphorylation-coupled Lys310 acetylation controls transcriptional elongation of inflammatory cytokines in respiratory syncytial virus infection. J. Virol. 85:11752-11769.
11. Tian B, Zhang Y, Luxon BA, Garofalo RP, Casola A, Sinha M, Brasier AR. 2002. Identification of NF-kappaB-dependent gene networks in respiratory syncytial virus-infected cells. J. Virol. 76:6800-6814.
12. Zhang Y, Luxon BA, Casola A, Garofalo RP, Jamaluddin M, Brasier AR. 2001. Expression of respiratory syncytial virus-induced chemokine gene networks in lower airway epithelial cells revealed by cDNA microarrays. J. Virol. 75:9044-9058.
13. Casola A, Garofalo RP, Jamaluddin M, Vlahopoulos S, Brasier AR. 2000. Requirement of a novel upstream response element in respiratory syncytial virus-induced IL-8 gene expression. J. Immunol. 164:5944- 5951.
14. Liu P, Jamaluddin M, Li K, Garofalo RP, Casola A, Brasier AR. 2007. Retinoic acid-inducible gene I mediates early antiviral response and Tolllike receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells. J. Virol. 81:1401-1411.
15. Bibeau-Poirier A, Servant MJ. 2008. Roles of ubiquitination in patternrecognition receptors and type I interferon receptor signaling. Cytokine 43:359-367.
16. Loo YM, Gale M, Jr. 2011. Immune signaling by RIG-I-like receptors. Immunity 34:680-692.
17. Thompson MR, Kaminski JJ, Kurt-Jones EA, Fitzgerald KA. 2011. Pattern recognition receptors and the innate immune response to viral infection. Viruses 3:920-940.
18. Yoneyama M, Fujita T. 2008. Structural mechanism of RNA recognition by the RIG-I-like receptors. Immunity 29:178-181.
19. Yount JS, Gitlin L, Moran TM, Lopez CB. 2008. MDA5 participates in the detection of paramyxovirus infection and is essential for the early activation of dendritic cells in response to Sendai virus defective interfering particles. J. Immunol. 180:4910-4918.
20. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii KJ, Takeuchi O, Akira S. 2005. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6:981-988.
21. Seth RB, Sun L, Ea CK, Chen ZJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF-3. Cell 122:669-682.
22. Maelfait J, Beyaert R. 2012. Emerging role of ubiquitination in antiviral RIG-I signaling. Microbiol. Mol. Biol. Rev. 76:33-45.
23. O'Neill LA, Bowie AG. 2010. Sensing and signaling in antiviral innate immunity. Curr. Biol. 20:R328-R333. doi:10.1016/j.cub.2010.01.044.
24. Jamaluddin M, Wang S, Garofalo RP, Elliott T, Casola A, Baron S, Brasier AR. 2001. IFN-beta mediates coordinate expression of antigenprocessing genes in RSV-infected pulmonary epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 280:L248-L257.
25. Garofalo R, Mei F, Espejo R, Ye G, Haeberle H, Baron S, Ogra PL, Reyes VE. 1996. Respiratory syncytial virus infection of human respiratory epithelial cells up-regulates class IMHCexpression through the induction of IFN-beta and IL-1 alpha. J. Immunol. 157:2506-2513.
26. Durbin JE, Johnson TR, Durbin RK, Mertz SE, Morotti RA, Peebles RS, Graham BS. 2002. The role of IFN in respiratory syncytial virus pathogenesis. J. Immunol. 168:2944-2952.
27. Liu P, Lu M, Tian B, Li K, Garofalo RP, Prusak D, Wood TG, Brasier AR. 2009. Expression of an IKKgamma splice variant determines IRF3 and canonical NF-kappaB pathway utilization in ssRNA virus infection. PLoS One 4:e8079. doi:10.1371/journal.pone.0008079.
28. Guerrero-Plata A, Baron S, Poast JS, Adegboyega PA, Casola A, Garofalo RP. 2005. Activity and regulation of alpha interferon in respiratory syncytial virus and human metapneumovirus experimental infections. J. Virol. 79:10190-10199.
29. Schoggins JW, Rice CM. 2011. Interferon-stimulated genes and their antiviral effector functions. Curr. Opin. Virol. 1:519-525.
30. Sadler AJ, Williams BR. 2008. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 8:559-568.
31. Wacher C, Muller M, Hofer MJ, Getts DR, Zabaras R, Ousman SS, Terenzi F, Sen GC, King NJ, Campbell IL. 2007. Coordinated regulation and widespread cellular expression of interferon-stimulated genes (ISG) ISG-49, ISG-54, and ISG-56 in the central nervous system after infection with distinct viruses. J. Virol. 81:860-871.
32. Levy D, Larner A, Chaudhuri A, Babiss LE, Darnell JE, Jr. 1986. Interferon-stimulated transcription: isolation of an inducible gene and identification of its regulatory region. Proc. Natl. Acad. Sci. U. S. A. 83: 8929-8933.
33. Terenzi F, Hui DJ, Merrick WC, Sen GC. 2006. Distinct induction patterns and functions of two closely related interferon-inducible human genes, ISG54 and ISG56. J. Biol. Chem. 281:34064-34071.
34. Peters KL, Smith HL, Stark GR, Sen GC. 2002. IRF-3-dependent, NFkappaB and JNK-independent activation of the 561 and IFN-beta genes in response to double-stranded RNA. Proc. Natl. Acad. Sci. U. S. A. 99:6322- 6327.
35. Weaver BK, Kumar KP, Reich NC. 1998. Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNAactivated transcription factor DRAF1. Mol. Cell. Biol. 18:1359-1368.
36. Zhou Q, Li T, Price DH. 2012. RNA polymerase II elongation control. Annu. Rev. Biochem. 81:119-143.
37. Chiba K, Yamamoto J, Yamaguchi Y, Handa H. 2010. Promoterproximal pausing and its release: molecular mechanisms and physiological functions. Exp. Cell Res. 316:2723-2730.
38. Ray S, Ju Sun XH, Finnerty CC, Herndon DN, Brasier AR. 10 January 2013. The IL-6 trans-signaling-STAT3 pathway mediates ECM and cellular proliferation in fibroblasts from hypertrophic scar. J. Invest. Dermatol. [Epub ahead of print.] doi:10.1038/jid.2012.499.
39. Ueba O. 1978. Respiratory syncytial virus. I. Concentration and purification of the infectious virus. Acta Med. Okayama 32:265-272.
40. Akagi T, Sasai K, Hanafusa H. 2003. Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformation. Proc. Natl. Acad. Sci. U. S. A. 100:13567-13572.
41. Naviaux RK, Costanzi E, Haas M, Verma IM. 1996. The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses. J. Virol. 70:5701-5705.
42. Tian B, Nowak DE, Jamaluddin M, Wang S, Brasier AR. 2005. Identification of direct genomic targets downstream of the nuclear factorkappaB transcription factor mediating tumor necrosis factor signaling. J. Biol. Chem. 280:17435-17448.
43. Nowak DE, Tian B, Brasier AR. 2005. Two-step cross-linking method for identification of NF-kappaB gene network by chromatin immunoprecipitation. Biotechniques 39:715-725.
44. Tian B, Yang J, Brasier AR. 2012. Two-step cross-linking for analysis of protein-chromatin interactions. Methods Mol. Biol. 809:105-120.
45. Zhao Y, Tian B, Edeh CB, Brasier AR. 15 February 2013. Quantitation of the dynamic profiles of the innate immune response using multiplex selected reaction monitoring-mass spectrometry. Mol. Cell. Proteomics [Epub ahead of print.] doi:10.1074/mcp.M112.023465.
46. Zhao Y, Brasier AR. 11 February 2013. Applications of selected reaction monitoring (SRM)-mass spectrometry (MS) for quantitative measurement of signaling pathways. Methods [Epub ahead of print.] doi:10.1016/ j.ymeth.2013.02.001.
47. Zhao Y, Widen SG, Jamaluddin M, Tian B, Wood TG, Edeh CB, Brasier AR. 2011. Quantification of activated NF-kappaB/RelA complexes using ssDNA aptamer affinity-stable isotope dilution-selected reaction monitoring- mass spectrometry. Mol. Cell. Proteomics 10(6):M111.008771. doi:10.1074/mcp.M111.008771.
48. Yang Z, Zhu Q, Luo K, Zhou Q. 2001. The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription. Nature 414: 317-322.
49. Kalita MK, Sargsyan K, Tian B, Paulucci-Holthauzen A, Najm HN, Debusschere BJ, Brasier AR. 2011. Sources of cell-to-cell variability in canonical nuclear factor-kappaB (NF-kappaB) signaling pathway inferred from single cell dynamic images. J. Biol. Chem. 286:37741-37757.
50. Foster KA, Oster CG, Mayer MM, Avery ML, Audus KL. 1998. Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolism. Exp. Cell Res. 243:359-366.
51. Spann KM, Tran KC, Collins PL. 2005. Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-kappaB, and proinflammatory cytokines. J. Virol. 79: 5353-5362.
52. Forbus J, Spratt H, Wiktorowicz J, Wu Z, Boldogh I, Denner L, Kurosky A, Brasier RC, Luxon B, Brasier AR. 2006. Functional analysis of the nuclear proteome of human A549 alveolar epithelial cells by HPLChigh resolution 2-D gel electrophoresis. Proteomics 6:2656-2672.
53. Gomes NP, Bjerke G, Llorente B, Szostek SA, Emerson BM, Espinosa JM. 2006. Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program. Genes Dev. 20:601-612.
54. Krystof V, Cankar P, Frysová I, Slouka J, Kontopidis G, Dzubák P, Hajdúch M, Srovnal J, de Azevedo WF, Jr, Orság M, Paprskárová M, Rolcík J, Látr A, Fischer PM, Strnad M. 2006. 4-Arylazo-3, 5-diamino- 1H-pyrazoleCDKinhibitors: SAR study, crystal structure in complex with CDK2, selectivity, and cellular effects. J. Med. Chem. 49:6500-6509.
55. Sims RJ, III, Belotserkovskaya R, Reinberg D. 2004. Elongation by RNA polymerase II: the short and long of it. Genes Dev. 18:2437-2468.
56. Yan N, Chen ZJ. 2012. Intrinsic antiviral immunity. Nat. Immunol. 13:214-222.
57. Medzhitov RT, Horng T. 2009. Transcriptional control of the inflammatory response. Nat. Rev. Immunol. 9:692-703.
58. Smale ST. 2012. Transcriptional regulation in the innate immune system. Curr. Opin. Immunol. 24:51-57.
59. Shiama N. 1997. The p300/CBP family: integrating signals with transcription factors and chromatin. Trends Cell Biol. 7:230-236.
60. Parekh BS, Maniatis T. 1999. Virus infection leads to localized hyperacetylation of histones H3 and H4 at the IFN-beta promoter. Mol. Cell 3:125-129.
61. Jang MK, Mochizuki K, Zhou M, Jeong HS, Brady JN, Ozato K. 2005. The bromodomain protein BRD4 is a positive regulatory component of P-TEFb and stimulatesRNApolymerase II-dependent transcription. Mol. Cell 19:523-534.
62. Nechaev S, Adelman K. 2011. Pol II waiting in the starting gates: regulating the transition from transcription initiation into productive elongation. Biochim. Biophys. Acta 1809:34-45.
63. Peterlin BM, Price DH. 2006. Controlling the elongation phase of transcription with P-TEFb. Mol. Cell 23:297-305.
64. Hargreaves DC, Horng T, Medzhitov R. 2009. Control of inducible gene expression by signal-dependent transcriptional elongation. Cell 138:129- 145.
65. Zhao R, Nakamura T, Fu Y, Lazar Z, Spector DL. 2011. Gene bookmarking accelerates the kinetics of post-mitotic transcriptional reactivation. Nat. Cell Biol. 13:1295-1304.
66. Luo Z, Lin C, Shilatifard A. 2012. The super elongation complex (SEC) family in transcriptional control. Nat. Rev. Mol. Cell Biol. 13:543-547.
67. Huang B, Yang XD, Zhou MM, Ozato K, Chen LF. 2009. BRD4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA. Mol. Cell. Biol. 29:1375-1387.
68. Barboric M, Nissen RM, Kanazawa S, Jabrane-Ferrat N, Peterlin BM. 2001. NF-kappaB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Mol. Cell 8:327-337.
69. Nowak DE, Tian B, Jamaluddin M, Boldogh I, Vergara LA, Choudhary S, Brasier AR. 2008. RelA Ser276 phosphorylation is required for activation of a subset of NF-kappaB-dependent genes by recruiting cyclindependent kinase 9/cyclin T1 complexes. Mol. Cell. Biol. 28:3623-3638.
70. Rahl PB, Lin CY, Seila AC, Flynn RA, McCuine S, Burge CB, Sharp PA, Young RA. 2010. c-Myc regulates transcriptional pause release. Cell 141: 432-445.
71. Hou T, Ray S, Brasier AR. 2007. The functional role of an interleukin 6-inducible CDK9.STAT3 complex in human gamma-fibrinogen gene expression. J. Biol. Chem. 282:37091-37102.
72. Schmerwitz UK, Sass G, Khandoga AG, Joore J, Mayer BA, Berberich N, Totzke F, Krombach F, Tiegs G, Zahler S, Vollmar AM, Fürst R. 2011. Flavopiridol protects against inflammation by attenuating leukocyteendothelial interaction via inhibition of cyclin-dependent kinase 9. Arterioscler. Thromb. Vasc. Biol. 31:280-288.
73. Shapiro GI. 2004. Preclinical and clinical development of the cyclindependent kinase inhibitor flavopiridol. Clin. Cancer Res. 10(12 part 2): 4270s-4275s.
74. Bancerek J, Poss ZC, Steinparzer I, Sedlyarov V, Pfaffenwimmer T, Mikulic I, Dölken L, Strobl B, Müller M, Taatjes DJ, Kovarik P. 2013. CDK8 kinase phosphorylates transcription factor STAT1 to selectively regulate the interferon response. Immunity 38:250-262.